![Ian Alexander Francis Miscampbell](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ian Alexander Francis Miscampbell
Chairman at Leucid Bio Ltd.
Profile
Ian Alexander Francis Miscampbell is currently the Chairman of Leucid Bio Ltd.
and a Director of Adorx Therapeutics Ltd.
He is also the Managing Partner of Sixth Element Capital LLP since 2011.
In the past, he worked as the Finance Director of Witham Contract Manufacturing Ltd.
in 2007-2008, Director of Crawford Healthcare Ltd.
in 2009, and Chief Financial Officer of York Pharma Plc, Microscience Ltd., and Oxford Immunotec Ltd.
Ian Alexander Francis Miscampbell active positions
Companies | Position | Start |
---|---|---|
Sixth Element Capital LLP
![]() Sixth Element Capital LLP Investment ManagersFinance Sixth Element Capital LLP is a venture capital firm headquartered in the UK. The firm founded in 2011 by Ralph Villiger. | Private Equity Investor | 2011-07-31 |
Adorx Therapeutics Ltd.
![]() Adorx Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Adorx Therapeutics Ltd. provides biotechnology, health care and therapeutics services. The company is headquartered in Edinburgh, the United Kingdom. | Director/Board Member | - |
Leucid Bio Ltd.
![]() Leucid Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Leucid Bio Ltd. is a clinical-stage biotechnology company based in London, UK. The British company develops novel, lateral car cell therapies for the treatment of refractory cancers, with a focus on developing next-generation cell therapies for the benefit of individuals with hard-to-treat solid tumors. The company's operations are based at Guys Hospital, enabling them to maintain a patient-centric focus. Leucid's goal is to develop CAR-T therapies with more durable responses, improving treatment outcomes and saving the lives of patients with refractory cancers. Leucid was established to translate 20 years of Kings College research in the CAR-T field and is led by a highly experienced management team, including scientific founder John Maher. Filippo Joseph Petti has been the CEO of the company since 2023. | Chairman | - |
Former positions of Ian Alexander Francis Miscampbell
Companies | Position | End |
---|---|---|
Crawford Healthcare Ltd.
![]() Crawford Healthcare Ltd. Medical DistributorsDistribution Services Crawford Healthcare Ltd. develops, manufactures, and supplies dermatological, woundcare, and diagnostic products. It offers SunSense, QV, SilDerm, Cuplex, Chemotechnique, Zindaclin, ViTix and ViTicolor, and Chemo Nickel and Cobalt test. The company was founded in 1996 and is headquartered in Knutsford, the United Kingdom. | Director/Board Member | 2009-07-28 |
Witham Contract Manufacturing Ltd.
![]() Witham Contract Manufacturing Ltd. Pharmaceuticals: MajorHealth Technology Witham Contract Manufacturing Ltd. manufactures and distributes pharmaceutical and healthcare products. It offers natural, botanical and plant extracts for the food, drink, pharmaceutical and related industries. The company was founded on December 23, 1912 and is headquartered in Southampton, the United Kingdom. | Director of Finance/CFO | 2008-10-23 |
Microscience Ltd.
![]() Microscience Ltd. Pharmaceuticals: MajorHealth Technology Microscience is an emerging vaccine company which is primarily involved in the discovery and development of innovative, rationally designed vaccines and immunotherapeutics for the prevention and treatment of disease in areas that the Company believes to represent a significant opportunity for new vaccines | Director of Finance/CFO | 2005-06-26 |
York Pharma Plc
![]() York Pharma Plc Pharmaceuticals: MajorHealth Technology York Pharma Plc activity is acquiring, developing and commercialising prescription dermatological products. It focuses on a dermatological product called abafungin, a topical therapy intended for the treatment of fungal infections and some mixed microbial infections. The Group's product will be marketed under the trade mark Abasol. The Group's other product brands are Sabarep and Vampex. The Group operates in the United Kingdom, Japan and Germany. | Director of Finance/CFO | - |
Oxford Immunotec Ltd.
![]() Oxford Immunotec Ltd. Medical SpecialtiesHealth Technology Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom. | Director of Finance/CFO | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 8 |
---|---|
York Pharma Plc
![]() York Pharma Plc Pharmaceuticals: MajorHealth Technology York Pharma Plc activity is acquiring, developing and commercialising prescription dermatological products. It focuses on a dermatological product called abafungin, a topical therapy intended for the treatment of fungal infections and some mixed microbial infections. The Group's product will be marketed under the trade mark Abasol. The Group's other product brands are Sabarep and Vampex. The Group operates in the United Kingdom, Japan and Germany. | Health Technology |
Microscience Ltd.
![]() Microscience Ltd. Pharmaceuticals: MajorHealth Technology Microscience is an emerging vaccine company which is primarily involved in the discovery and development of innovative, rationally designed vaccines and immunotherapeutics for the prevention and treatment of disease in areas that the Company believes to represent a significant opportunity for new vaccines | Health Technology |
Witham Contract Manufacturing Ltd.
![]() Witham Contract Manufacturing Ltd. Pharmaceuticals: MajorHealth Technology Witham Contract Manufacturing Ltd. manufactures and distributes pharmaceutical and healthcare products. It offers natural, botanical and plant extracts for the food, drink, pharmaceutical and related industries. The company was founded on December 23, 1912 and is headquartered in Southampton, the United Kingdom. | Health Technology |
Oxford Immunotec Ltd.
![]() Oxford Immunotec Ltd. Medical SpecialtiesHealth Technology Oxford Immunotec Ltd. operates as a medical diagnostic company. It develops and sells medical diagnostic products. The company was founded by Peter Wrighton-Smith in 2002 and is headquartered in Abingdon, the United Kingdom. | Health Technology |
Crawford Healthcare Ltd.
![]() Crawford Healthcare Ltd. Medical DistributorsDistribution Services Crawford Healthcare Ltd. develops, manufactures, and supplies dermatological, woundcare, and diagnostic products. It offers SunSense, QV, SilDerm, Cuplex, Chemotechnique, Zindaclin, ViTix and ViTicolor, and Chemo Nickel and Cobalt test. The company was founded in 1996 and is headquartered in Knutsford, the United Kingdom. | Distribution Services |
Sixth Element Capital LLP
![]() Sixth Element Capital LLP Investment ManagersFinance Sixth Element Capital LLP is a venture capital firm headquartered in the UK. The firm founded in 2011 by Ralph Villiger. | Finance |
Adorx Therapeutics Ltd.
![]() Adorx Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services Adorx Therapeutics Ltd. provides biotechnology, health care and therapeutics services. The company is headquartered in Edinburgh, the United Kingdom. | Commercial Services |
Leucid Bio Ltd.
![]() Leucid Bio Ltd. Miscellaneous Commercial ServicesCommercial Services Leucid Bio Ltd. is a clinical-stage biotechnology company based in London, UK. The British company develops novel, lateral car cell therapies for the treatment of refractory cancers, with a focus on developing next-generation cell therapies for the benefit of individuals with hard-to-treat solid tumors. The company's operations are based at Guys Hospital, enabling them to maintain a patient-centric focus. Leucid's goal is to develop CAR-T therapies with more durable responses, improving treatment outcomes and saving the lives of patients with refractory cancers. Leucid was established to translate 20 years of Kings College research in the CAR-T field and is led by a highly experienced management team, including scientific founder John Maher. Filippo Joseph Petti has been the CEO of the company since 2023. | Commercial Services |
- Stock Market
- Insiders
- Ian Alexander Francis Miscampbell